CD19 CAR-T induces complete and durable remission in cold agglutinin syndrome associated relapse and refractory diffuse large B cell lymphoma.
APA
Ding W, Li A, et al. (2026). CD19 CAR-T induces complete and durable remission in cold agglutinin syndrome associated relapse and refractory diffuse large B cell lymphoma.. Leukemia & lymphoma, 67(2), 448-450. https://doi.org/10.1080/10428194.2025.2573873
MLA
Ding W, et al.. "CD19 CAR-T induces complete and durable remission in cold agglutinin syndrome associated relapse and refractory diffuse large B cell lymphoma.." Leukemia & lymphoma, vol. 67, no. 2, 2026, pp. 448-450.
PMID
41139917
같은 제1저자의 인용 많은 논문 (5)
- Omission of clinical target volume in radiotherapy for unresectable stage III non-small cell lung cancer: a propensity score matching analysis.
- Biologically explicable multimodal model predicting local tumor progression and tumor invasiveness of hepatocellular carcinoma.
- Burden of prostate cancer in older adults, 1990-2021: a systematic analysis based on the global burden of disease study 2021.
- Contrast-enhanced ultrasound-based AI model for multi-classification of focal liver lesions.
- Neuropeptide Precursor VGF Promotes Neuroendocrine Differentiation and Cancer-Associated Fibroblast Activation in Small Cell Lung Cancer.